Provided by Tiger Fintech (Singapore) Pte. Ltd.

ZYMEWORKS INC (US)

12.13
-0.0700-0.57%
Volume:263.73K
Turnover:3.20M
Market Cap:845.26M
PE:-8.07
High:12.44
Open:12.21
Low:11.92
Close:12.20
Loading ...

BRIEF-Zymeworks' Zanidatamab Approved in China for HER2-High Expression Biliary Tract Cancer

Reuters
·
30 May

Zymeworks Inc. Secures NMPA Approval for Zanidatamab in China, Set to Receive $20 Million Milestone Payment from BeOne Medicines

Reuters
·
30 May

Zymeworks Announces Nmpa Approval of Zanidatamab in China for Adults With Previously Treated, Unresectable or Metastatic Her2-High Expression (Ihc3+) Biliary Tract Cancer

THOMSON REUTERS
·
30 May

Zymeworks Inc - Zym Works to Receive $20 Mln Milestone Payment From Beone Medicines

THOMSON REUTERS
·
30 May

Zymeworks Inc - Zym Works Eligible for up to 19.5% Royalties on Net Sales

THOMSON REUTERS
·
30 May

Zymeworks Inc. to Present Oncology Portfolio at Upcoming ASCO Annual Meeting

Reuters
·
23 May

Zymeworks Inc. to Participate in Goldman Sachs Global Healthcare Conference

Reuters
·
21 May

Zymeworks Initiated at Buy by TD Securities

Dow Jones
·
20 May

Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday

MT Newswires Live
·
20 May

TD Cowen Initiates Coverage on Zymeworks With Buy Rating

MT Newswires Live
·
20 May

Zymeworks Inc : TD Cowen Initiates Coverage With Buy Rating

THOMSON REUTERS
·
20 May

Zymeworks: Buy Rating Driven by Innovative Pipeline and Strategic Partnerships

TIPRANKS
·
20 May

Zymeworks initiated with a Buy at TD Cowen

TIPRANKS
·
20 May

EcoR1 Capital Reports Acquisition of Common Shares in Zymeworks Inc

Reuters
·
20 May

Zymeworks Shows Positive Preclinical Data for Experimental Respiratory Imflammation Treatment

MT Newswires Live
·
20 May

Zymeworks presents new ZW1528 data at ATS conference

TIPRANKS
·
20 May

Zymeworks Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

Zymeworks Q1 EPS $(0.30) Beats $(0.41) Estimate, Sales $27.11M Beat $20.65M Estimate

Benzinga
·
09 May

BRIEF-Zymeworks Q1 Operating Expenses USD 52.723 Million

Reuters
·
09 May

Zymeworks Inc expected to post a loss of 41 cents a share - Earnings Preview

Reuters
·
07 May